Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Pharmaceutical Business Review
Return to: PBR Home
Top Headlines

Pharmaceutical Business Review

Pfizer agrees to acquire Baxter's vaccines business for $635m Pfizer has entered into a definitive agreement to acquire two commercially marketed vaccines and portion of related production facilities from Baxter International for $635m. Production & Manufacturing > Manufacturing > News
Angelini to commercialize Durata's Dalbavancin in certain European Territories, Russia and Turkey By PBR Staff Writer
Durata Therapeutics International, the Dutch subsidiary of US-based Durata Therapeutics, has entered into a license and supply agreement with Angelini, an international group leader in the pharmaceutical and mass-market sectors, to commercialize dalbavancin in 36 countries.
Contract Research & Services > Contract Services > News Anika Therapeutics, Medline enter commercialization deal for Hyalomatrix By PBR Staff Writer
US-based Anika Therapeutics has entered into a new agreement with Medline Industries to commercialize the company's advanced wound care product 'Hyalomatrix', in the US on an exclusive basis through 2019.
Contract Research & Services > Contract Services > News InnoPharma launches Olanzapine for injection, 10mg/vial in Canada By PBR Staff Writer
InnoPharma, a sterile product development company, has launched Olanzapine for Injection, 10mg/vial (the generic equivalent of Zyprexa injection), in Canada, for the rapid control of agitation and disturbed behaviors in patients with schizophrenia or bipolar I mania.
Drug Research > Drug Delivery > News
Incyte, Genentech to assess combination of two new cancer immunotherapies By PBR Staff Writer
US-based biopharmaceutical firm Incyte has entered into a clinical trial agreement with Genentech to assess the combination of two new cancer immunotherapies for patients with non-small cell lung cancer (NSCLC).
Drug Research > Drug Discovery & Development > News Bayer’s Eylea gets FDA approval for diabetic macular edema treatment By PBR Staff Writer
Bayer has received approval from the US Food and Drug Administration (FDA) for aflibercept solution for injection into the eye (EYLEA) to treat diabetic macular edema (DME) in the US.
Drug Research > Drug Delivery > News Immune Pharmaceuticals begins patient screening for Bertilimumab Phase II clinical trial in Bullous Pemphigoid Immune Pharmaceuticals has initiated the screening of patients for a Phase II proof of concept clinical trial exploring the safety and efficacy of bertilimumab in the treatment of moderate to severe bullous pemphigoid.
Contract Research & Services > Clinical Trials > News

Latest News and Insight by Sector

Production & Manufacturing

Axxess Pharma gets $2m financing to fulfill increased rate of purchase orders
Axxess Pharma Inc. is pleased to announce through its wholly owned subsidiary AllStar Health Brands Inc., that they have secured $2,000,000 USD in financing. Funds will be used to fulfill current purchase orders and increase marketing and inventory of products.
Production & Manufacturing > OTC > News
Pfizer agrees to acquire Baxter's vaccines business for $635m
By PBR Staff Writer
Pfizer has entered into a definitive agreement to acquire two commercially marketed vaccines and portion of related production facilities from Baxter International for $635m.
Production & Manufacturing > Manufacturing > News

Drug Research

InnoPharma launches Olanzapine for injection, 10mg/vial in Canada
By PBR Staff Writer
InnoPharma, a sterile product development company, has launched Olanzapine for Injection, 10mg/vial (the generic equivalent of Zyprexa injection), in Canada, for the rapid control of agitation and disturbed behaviors in patients with schizophrenia or bipolar I mania.
Drug Research > Drug Delivery > News
Incyte, Genentech to assess combination of two new cancer immunotherapies
By PBR Staff Writer
US-based biopharmaceutical firm Incyte has entered into a clinical trial agreement with Genentech to assess the combination of two new cancer immunotherapies for patients with non-small cell lung cancer (NSCLC).
Drug Research > Drug Discovery & Development > News

Inward Investment

Amgen to buy Onyx Pharmaceuticals for $10.4bn
By PBR Staff Writer
Biotechnology company Amgen has reached a deal to buy all outstanding shares of California-based Onyx Pharmaceuticals for $125 per share in cash.
Inward Investment > News
Johnson & Johnson completes purchase of Aragon Pharmaceuticals
By PBR Staff Writer
Johnson & Johnson has completed the acquisition of Aragon Pharmaceuticals, a pharmaceutical discovery and development company focused on drugs to hormonally-driven cancers.
Inward Investment > News

Packaging

Biologics adds frozen storage capabilities to clinical research services
By PBR Staff Writer
Biologics’ Clinical Research Services has announced the addition of frozen storage capabilities to its state-of-the-art facilities and cold-chain packaging and distribution.
Packaging > News
ATMI, D-Lab launch new Sterile Pyrofree vials
By PBR Staff Writer
US-based technology firm ATMI in partnership with Disposable Lab (D-Lab), a French contract-manufacturing company, has launched a line of pyrogen-free vials in order to meet biopharmaceutical filling and final packaging needs.
Packaging > News

Contract Research & Services

Angelini to commercialize Durata's Dalbavancin in certain European Territories, Russia and Turkey
By PBR Staff Writer
Durata Therapeutics International, the Dutch subsidiary of US-based Durata Therapeutics, has entered into a license and supply agreement with Angelini, an international group leader in the pharmaceutical and mass-market sectors, to commercialize dalbavancin in 36 countries.
Contract Research & Services > Contract Services > News
Anika Therapeutics, Medline enter commercialization deal for Hyalomatrix
By PBR Staff Writer
US-based Anika Therapeutics has entered into a new agreement with Medline Industries to commercialize the company's advanced wound care product 'Hyalomatrix', in the US on an exclusive basis through 2019.
Contract Research & Services > Contract Services > News

Automation

Theraclone enters into agreement with Gilead Sciences for broadly neutralizing HIV antibodies
Theraclone Sciences, a therapeutic antibody discovery and development company, announced today that it has entered into an agreement with Gilead Sciences under which Gilead received an exclusive license to develop and commercialize products incorporating Theraclone’s broadly neutralizing HIV-antibodies for therapeutic applications in HIV.
Automation > IT & Software > News
Cellectis sells Swedish subsidiary Cellectis to Takara Bio
Cellectis, a leader in the development of adoptive immunotherapies based on engineered allogeneic CART cells (UCART) has announced the sale of its subsidiary Cellectis AB to the Japanese Company Takara Bio.
Automation > IT & Software > News

Regulatory Affairs

European Commission approves BMS- Pfizer's Eliquis to treat DVT, PE
By PBR Staff Writer
The European Commission (EC) has approved Bristol-Myers Squibb (BMS) and Pfizer's Eliquis, an oral selective Factor Xa inhibitor, for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as prevention of recurrent DVT and PE in adults.
Regulatory Affairs > News
Roche gets European approval for leukemia treatment Gazyvaro
By PBR Staff Writer
Swiss health-care firm Roche has received approval from the European Commission for Gazyvaro (obinutuzumab) in combination with chlorambucil chemotherapy to treat people with previously untreated chronic lymphocytic leukemia (CLL) who have comorbidities making them unsuitable for an intensive therapy (full-dose fludarabine based therapy).
Regulatory Affairs > News

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Reports Buy online from $250


Data-Label.co.uk DataLabel have been supplying
the medical industry with labels
for over 10 years

Manufactures of
healthcare packaging
machinery